Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
Open Access
- 17 May 2022
- journal article
- research article
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 7 (1) , 1-13
Abstract
The outbreak of coronavirus disease 2019 (COVID-19) has posed great threats to global health and economy. Several effective vaccines are available now, but additional booster immunization is required to retain or increase the immune responses owing to waning immunity and the emergency of new variant strains. The deficiency of intramuscularly delivered vaccines to induce mucosal immunity urged the development of mucosal vaccines. Here, we developed an adjuvanted intranasal RBD vaccine and monitored its long-term immunogenicity against both wild-type and mutant strains of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), including Omicron variants, in mice. Three-dose intranasal immunization with this vaccine induced and maintained high levels of neutralizing IgG antibodies in the sera for at least 1 year. Strong mucosal immunity was also provoked, including mucosal secretory IgA and lung-resident memory T cells (TRM). We also demonstrated that the long-term persistence of lung TRM cells is a consequence of local T-cell proliferation, rather than T-cell migration from lymph nodes. Our data suggested that the adjuvanted intranasal RBD vaccine is a promising vaccine candidate to establish robust, long-lasting, and broad protective immunity against SARS-CoV-2 both systemically and locally.Keywords
This publication has 50 references indexed in Scilit:
- CD4+ T Cell Help Guides Formation of CD103+ Lung-Resident Memory CD8+ T Cells during Influenza Viral InfectionImmunity, 2014
- Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulationBiomaterials, 2014
- Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cellsNature Immunology, 2013
- Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse LungAmerican Journal of Respiratory Cell and Molecular Biology, 2013
- Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infectionJournal of Leukocyte Biology, 2013
- Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell SubsetsImmunity, 2013
- Airway CD8+ T cells induced by pulmonary DNA immunization mediate protective anti-viral immunityMucosal Immunology, 2013
- Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensNature Biotechnology, 2012
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunityImmunological Reviews, 2010
- Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell HelpScience, 2003